A paper published October 2025 assessed whether non-diabetic overweight or obese patients who took GLP-1 agonists were more likely to develop AMD from no disease at baseline, compared to patients who took other weight loss drugs
They are typically administered via subcutaneous injections
The individual peptides have human research behind them, but high-quality studies of the specific CJC-1295 plus Ipamorelin combination are limited, and much of what exists comes from small or animal studies (Injectable Peptide Therapy review, 2026)
Off-Label: Coadministered with pyridostigmine in the treatment of myasthenia gravis for side effect management - to reduce muscarinic symptoms resulting from inhibition of acetylcholinesterase (Bird, 2026)
Neither do you have to wait for the L-Carnitine to kick in
Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure